Skip to content
Screener

Eton Pharmaceuticals, Inc. ETON Finance Lease Liabilities

Discontinued — last reported Q1 '26

Finance Lease Liabilities at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$48K-69.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$3M-80.7%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$849K-58.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$0-100%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K—
Free cash flow$7.3M+251%

Valuation

See full
Market cap$1.26B+209%
Enterprise value$1.28B+208%
P/S14.6×+7.5×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%—
Net margin-9.5%-2.7pp
FCF margin17.1%—

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity1×-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 4:17 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001437749-26-017064

FAQ

What is Eton Pharmaceuticals, Inc.'s finance lease liabilities?
Eton Pharmaceuticals, Inc. (ETON) reported finance lease liabilities of $0 in Q1 2026.
What does finance lease liabilities mean?
Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.

Ask your AI about Eton Pharmaceuticals, Inc.'s finance lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude